Vanguard Personalized Indexing Management, LLC
Position in MDGL — Madrigal Pharmaceuticals, Inc.
CIK 1767306
OAKLAND, CA
Position in MDGL
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$728,104
-$184,304 QoQ
Shares Held
1,356
-22.2% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#220
of 411 holders
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 78%
Shared 0%
None 22%
Common Shares in MDGL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Vanguard Personalized Indexing Management, LLC holds $97,369,187 across 138 Biotechnology names. MDGL ranks #29 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
43,151 | $21,434,396 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
11,712 | $7,302,900 | |
| 3 | INCY |
Incyte Corp
|
34,556 | $3,917,268 | |
| 4 | ARGX |
Argenx SE
|
4,103 | $3,806,640 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
11,436 | $3,442,579 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
17,697 | $3,314,294 | |
| 7 | MRNA |
Moderna, Inc.
|
43,679 | $3,058,840 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
30,414 | $2,380,503 |
All Filings in MDGL
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $728,104 | 1,356 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $912,408 | 1,743 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $727,342 | 1,249 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $499,480 | 1,089 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $297,797 | 984 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $318,974 | 963 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $243,770 | 790 | Shares | Sole | 2025-02-10 | |
| 2024-06-30 | $203,956 | 728 | Shares | Sole | 2024-08-12 | |
| No filing history on record for this holder in this stock. | ||||||